Suchen
OrthoPediatrics Corp
KIDSZur Watchlist hinzufügen
19.950USD
+0.650+3.37%
Handelsschluss 07/02, 13:00（ET）Kurse um 15 Minuten verzögert
510.82MMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über OrthoPediatrics Corp Unternehmen
OrthoPediatrics Corp. is an orthopedic company, which is focused on advancing the field of pediatric orthopedics. The Company is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The Company sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. It markets 80 surgical and specialized bracing systems.
OrthoPediatrics Corp Informationen
BörsenkürzelKIDS
Name des UnternehmensOrthoPediatrics Corp
IPO-datumOct 12, 2017
CEOBailey (David R)
Anzahl der mitarbeiter562
WertpapierartOrdinary Share
GeschäftsjahresendeOct 12
Addresse2850 Frontier Drive
StadtWARSAW
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl46582
Telefon15742686379
Websitehttps://www.orthopediatrics.com/
BörsenkürzelKIDS
IPO-datumOct 12, 2017
CEOBailey (David R)
Führungskräfte von OrthoPediatrics Corp
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
Mr. Bryan W. Hughes
Mr. Bryan W. Hughes
Independent Director
Independent Director
32.66K
+35.01%
Mr. Samuel D. Riccitelli
Mr. Samuel D. Riccitelli
Independent Director
Independent Director
31.86K
+35.90%
Ms. Marie C. Infante, J.D.
Ms. Marie C. Infante, J.D.
Independent Director
Independent Director
31.20K
+36.65%
Ms. Kelly Fischer
Ms. Kelly Fischer
Director
Director
15.78K
+72.47%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David R. Bailey
Mr. David R. Bailey
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
417.16K
+28.56%
Mr. Fred L. Hite
Mr. Fred L. Hite
Chief Financial Officer, Chief Operating Officer, Director
Chief Financial Officer, Chief Operating Officer, Director
277.48K
--
Mr. Mark C. Throdahl
Mr. Mark C. Throdahl
Chairman of the Board
Chairman of the Board
201.81K
+5.67%
Mr. Joseph W. Hauser
Mr. Joseph W. Hauser
President of Trauma, Deformity and OPSB
President of Trauma, Deformity and OPSB
194.77K
--
Mr. Gregory A. Odle
Mr. Gregory A. Odle
President of Scoliosis
President of Scoliosis
187.74K
--
Mr. David R. Pelizzon
Mr. David R. Pelizzon
Independent Director
Independent Director
44.38K
+25.77%
Häufig gestellte Fragen
Wer sind die fünf größten Anteilseigner von OrthoPediatrics Corp?
Die fünf größten Anteilseigner von OrthoPediatrics Corp sind: Mr. David R. Bailey
Wie viele Institutionen halten Anteile an OrthoPediatrics Corp (KIDS)?
Mit Stand vom 2026Q1 halten 287 Institutionen Anteile an OrthoPediatrics Corp, mit einem Gesamtmarktwert von etwa 18.35M, was 71.44% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -360870.00 gestiegen.
Was ist die größte Einnahmequelle von OrthoPediatrics Corp?
Am 2026Q1 erzielte das Geschäft mit Trauma and Deformity für OrthoPediatrics Corp den höchsten Umsatz in Höhe von 166.30M, was 70.36% des Gesamtumsatzes entspricht.